The Pituitary-Thyroid Axis and Prolactin Secretion in Hemodialysis Patients in Two Endemic Regions of Eastern Germany

Abstract Introduction Endocrine disorders of the pituitary axes are frequent in patients with hemodialysis (CKD5D). The aim of this multicenter study (Leipzig (L), Quedlinburg and Blankenburg in the Harz region (Hz)) in CKD5D patients was to evaluate influences of CKD5D related factors, morphological and biochemical parameters, and serum iodine and prolactin concentrations on the pituitary-thyroid axis. Patients and Methods 170 patients (L n=58; Hz n=112) were included in this prospective, non-interventional, cross-sectional study. Mann-Whitney-U-test and bivariate correlation analyses with Spearman-Rho test (r correlation coefficient) were used in statistical analysis. Results TSH was higher in patients with prolactin concentrations>370 mIU/l (p=0.013), in patients with high flux membranes (p=0.0013) and in patients with longer dialysis vintage (p=0.04). Median iodine serum concentrations were slightly elevated in the Leipzig cohort (p=0.001) and correlated with fT4 (p<0.001, r=0.43) and albumin (p=0.001, r=0.245) but not with morphological signs. Albumin was correlated with fT3 (p<0.001, r=0.339) and fT4 (p<0.001, r=0.421). Prolactin was correlated with residual excretion rate (p=0.001, r=- 0.303) and thyroid volume (p=0.027, r=0.217). Conclusions In the assessment of the thyroid status in CKD5D patients, the synopsis of the clinical and nutritional status, comorbidities, ultrasound of the thyroid gland and laboratory results is necessary for further intervention with hormone replacement. Standardized reference values of the pituitary-thyroid axis should be critically evaluated and are still lacking in CKD5D.

[1]  Christopher T. Chan,et al.  Thyroid function in end stage renal disease and effects of frequent hemodialysis , 2017, Hemodialysis international. International Symposium on Home Hemodialysis.

[2]  D. Dutta,et al.  Hyperprolactinemia in Children with Subclinical Hypothyroidism , 2017, Journal of clinical research in pediatric endocrinology.

[3]  Connie M. Rhee,et al.  Thyroid Status and Mortality in a Prospective Hemodialysis Cohort , 2017, The Journal of clinical endocrinology and metabolism.

[4]  V. Pop,et al.  Thyroglobulin as a Functional Biomarker of Iodine Status in a Cohort Study of Pregnant Women in the United Kingdom , 2017, Thyroid : official journal of the American Thyroid Association.

[5]  D. Dutta,et al.  Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism. , 2016, European journal of internal medicine.

[6]  E. Martínez-Morillo,et al.  Variation of trace element concentrations in patients undergoing hemodialysis in the north of Spain , 2016, Scandinavian journal of clinical and laboratory investigation.

[7]  S. Skeaff,et al.  Thyroglobulin as a biomarker of iodine deficiency: a review. , 2014, Thyroid : official journal of the American Thyroid Association.

[8]  M. Rottmann,et al.  A Progress Report of the IFCC Committee for Standardization of Thyroid Function Tests , 2014, European Thyroid Journal.

[9]  T. Kitazono,et al.  Importance of specific reference values for evaluation of the deteriorating thyroid function in patients with end-stage renal disease on hemodialysis , 2014, Journal of Endocrinological Investigation.

[10]  T. Delibaşı,et al.  Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma , 2013, Clinical endocrinology.

[11]  J. Carrero,et al.  Chronic kidney disease and hypothalamic-pituitary axis dysfunction: the chicken or the egg? , 2013, Archives of medical research.

[12]  M. Zimmermann,et al.  Assessment of iodine nutrition in populations: past, present, and future. , 2012, Nutrition reviews.

[13]  J. Carrero,et al.  Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[14]  R. Paschke,et al.  Reduction of Thyroid Nodule Volume by Levothyroxine and Iodine Alone and in Combination: A Randomized, Placebo-Controlled Trial , 2011, The Journal of clinical endocrinology and metabolism.

[15]  A. Davenport,et al.  Does the choice of phosphate binder affect trace element levels in chronic kidney disease patients treated by regular haemodialysis? , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  E. Hodžić,et al.  Functional Thyroid Disorders Are More Common in Patients on Chronic Hemodialysis Compared with the General Population , 2011, Materia socio-medica.

[17]  K. Node,et al.  Ultrasonographic Detection of Thyroid Nodules in Hemodialysis Patients in Japan , 2010, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[18]  M. Tonelli,et al.  Trace elements in hemodialysis patients: a systematic review and meta-analysis , 2009, BMC medicine.

[19]  R. Pahlka,et al.  THE EFFECTS OF DIALYSIS ON 131I KINETICS AND DOSIMETRY IN THYROID CANCER PATIENTS—A PHARMACOKINETIC MODEL , 2006, Health physics.

[20]  D. Yavuz,et al.  Macroprolactin does not contribute to elevated levels of prolactin in patients on renal replacement therapy , 2005, Clinical endocrinology.

[21]  M. Myśliwiec,et al.  Thyroid function and morphology in kidney transplant recipients, hemodialyzed, and peritoneally dialyzed patients. , 2003, Transplantation proceedings.

[22]  Hirotoshi Nakamura,et al.  Low free thyroxine concentrations and deficient nocturnal surge of thyroid-stimulating hormone in haemodialysed patients compared with undialysed patients. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  C. Letizia,et al.  Effects of haemodialysis session on plasma beta-endorphin, ACTH and cortisol in patients with end-stage renal disease. , 1996, Scandinavian journal of urology and nephrology.

[24]  C. Foulks,et al.  Sexual dysfunction in the male dialysis patient: pathogenesis, evaluation, and therapy. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  M. Molitch,et al.  Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  L. Hegedüs,et al.  Thyroid gland volume and serum concentrations of thyroid hormones in chronic renal failure. , 1985, Nephron.

[27]  A. Katz,et al.  Prolactin metabolism in the rat: role of the kidney in degradation of the hormone. , 1981, The American journal of physiology.

[28]  C. García-Iglesias,et al.  The kinetics of the thyroid hormones and the peripheral conversion rate of thyroxine to triiodothyronine in acute liver insufficiency under experimental conditions. , 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[29]  J. Wauters,et al.  Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin. , 1980, The American journal of medicine.

[30]  C. Iglesias,et al.  Study of the Kinetics of the Thyroid Hormones and the Peripheral Conversion Rate of Thyroxine to Triiodothyronine in Acute Renal Insufficiency under Experimental Conditions , 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.